NCT02515422View on ClinicalTrials.gov

Subcutaneous Wound Infiltration of Ketamine or Bupivacaine Pain Perception After Cesarean Section

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Postoperative Pain
Interventions
DRUG

Ketamine

Subcutaneous infiltration of ketamine

DRUG

Bupivacaine

Subcutaneous infiltration of bupivacaine

DRUG

Placebo (0.9% saline solution)

Trial Locations (1)

Unknown

Kayseri Educational and Research Hospital, Kayseri

All Listed Sponsors
lead

Huseyin Aksoy

OTHER_GOV

NCT02515422 - Subcutaneous Wound Infiltration of Ketamine or Bupivacaine Pain Perception After Cesarean Section | Biotech Hunter | Biotech Hunter